Sangamo Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Sangamo Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sangamo Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sangamo Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Sangamo Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230392118A1 | Application | Generation of cd4+ effector and regulatory t cells from human pluripotent stem cells | C12N2501/15; C12N2501/2302; C12N2501/998; C12N2501/999; C12N2506/45; C12N5/0636 | December 07, 2023 |
| US11834686B2 | Grant | Engineered target specific base editors | C12N15/11; C12N15/63; C12N2310/20; C12N2310/3181; C12N2310/323; C12N2310/3231; C12N2800/80; C12N9/22; C12N9/78; C12Y305/04001; C12Y305/04002 | December 05, 2023 |
| CN117137947A | Application | Mhc细胞受体的靶向破坏 | C12N15/62; C12N2510/00; C12N5/0636; C12N9/22; A61K35/00; A61K35/17; A61K48/00; A61P35/00; C07K14/7051; C07K14/70521; C07K14/70539; C07K14/70596; C07K16/2803; C07K2319/02; C07K2319/33; C07K2319/70 | December 01, 2023 |
| US20230381225A1 | Application | Methods for the treatment of beta-thalassemia | C12N5/0634; A61K35/12; A61K9/0019; A61P7/00 | November 30, 2023 |
| US20230382962A1 | Application | Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene | C12N15/86; C12N9/22; A61K35/42; A61K38/00; C07K14/4712 | November 30, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer